Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 8/2006

01-08-2006 | Original Articles

Health literacy, antiretroviral adherence, and HIV-RNA suppression

A longitudinal perspective

Authors: Michael K. Paasche-Orlow, MD, MA, MPH, Debbie M. Cheng, ScD, Anita Palepu, MD, MPH, Seville Meli, MPH, Vincent Faber, MPH, Jeffrey H. Samet, MD, MA, MPH

Published in: Journal of General Internal Medicine | Issue 8/2006

Login to get access
Metadata
Title
Health literacy, antiretroviral adherence, and HIV-RNA suppression
A longitudinal perspective
Authors
Michael K. Paasche-Orlow, MD, MA, MPH
Debbie M. Cheng, ScD
Anita Palepu, MD, MPH
Seville Meli, MPH
Vincent Faber, MPH
Jeffrey H. Samet, MD, MA, MPH
Publication date
01-08-2006
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 8/2006
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1111/j.1525-1497.2006.00527.x

Other articles of this Issue 8/2006

Journal of General Internal Medicine 8/2006 Go to the issue

Original Articles

Limited literacy and mortality in the elderly

Original Articles

Impact of health literacy on longitudinal asthma outcomes

Original Articles

Low literacy impairs comprehension of prescription drug warning labels

Editorials

Literacy and health outcomes

Editorials

Improving literacy as a means to reducing health disparities

Introduction

Advancing the field of health literacy
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits